Drug Type Small molecule drug, Diagnostic radiopharmaceuticals |
Synonyms- |
Target |
Action antagonists |
Mechanism D2 receptor antagonists(Dopamine D2 receptor antagonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization |
License Organization- |
Drug Highest PhasePhase 1 |
First Approval Date- |
Regulation- |
Molecular FormulaC15H20Cl2N2O3 |
InChIKeyWAOQONBSWFLFPE-TXWZUYSVSA-N |
CAS Registry97849-54-2 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Brain Injuries, Traumatic | Phase 1 | United States | 18 Nov 2014 | |
Depressive Disorder | Phase 1 | Sweden | 01 Jan 2009 |
Early Phase 1 | 61 | mqtcotyboo = azqamzlntc vthoatiqph (ftwwizexct, psnlkwwbug - ppwcbpggfy) View more | - | 03 May 2023 | |||
Phase 4 | 88 | zjpzqeqjqv(zpzliqdbou) = lhbiillkom uyfigpentc (yxmmbadzfs, ynlunfbhlu - hemljsllqi) View more | - | 27 Apr 2020 |